[1] 饶慧瑛,魏来.从可治疗到可治愈再到消除.中华肝脏病杂志,2021,29:102-107. [2] WHO. Global health sector strategy on viral hepatitis 2016-2021[EB/OL].Geneva: World HealthOrganization,2016. https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/ [3] Chen Zhi-Wei,Li Zhao,Wang Qiao-He et al. Large Disparity between Prevalence and Treatment Rates for Hepatitis C in Western China. J Clin Transl Hepatol, 2018, 6: 385-390. [4] 冯小飞,丁国伟, 俞海亮,等. 医疗机构丙型肝炎诊断治疗现况研究.中国艾滋病性病,2020:247-249. [5] 陈雨欣,吴超.医院内丙型肝炎筛查和转诊路径的建立与实施.中华肝脏病杂志,2020,28:820-823. [6] 罗新华,梁跃东,彭虹,等.从全球丙型肝炎微消除模式到贵州省慢性丙型肝炎健康教育模式的探索.中华肝脏病杂志,2020,28:816-819. [7] 王荣华,李云涛,赵玲,等.基层全科医生在医联体内的角色定位研究.中国全科医学,2019,22:5-9. [8] Tan Chee-Kiat, Goh George Boon-Bee, Youn Jin et al. Public awareness and knowledge of liver health and diseases in Singapore. APASL 2021G-07. [9] World Hepatitis Alliance 2016. HCV Quest Global Patient Survey-China Report. https://www.worldhepatitisalliance.org/hcv-quest-global-patient-survey-china-en-report. [10] 章雨晨,孟娜娜,丁宏.分级诊疗制度下慢性病患者门诊服务利用分析——某三甲医院门诊慢性病患者调查.中国农村卫生事业管理,2017,37:1158-1160. [11] Smith S, Harmanci H, Hutin Y, et al. Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017. JHEP Rep,2019,1:81-89. [12] Lazarus JV, Safreed-Harmon K, Thursz MR, et al. The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations. Semin Liver Dis, 2018, 38: 181-192. |